Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Prostacyclin Market Report 2016

  • QYR679046
  • 124 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Prostacyclin

Revenue, means the sales value of Prostacyclin

This report studies sales (consumption) of Prostacyclin in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Actelion Pharmaceuticals Ltd.

United Therapeutics Corporation

Gilead sciences

Bayer AG

SteadyMed Ltd.

GlaxoSmithKline plc

Pfizer Inc.

Reata Pharmaceuticals Inc.

Arena Pharmaceuticals Inc.

Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Prostacyclin in each application, can be divided into

Health care

Clinic

Hospital

Table of Contents

United States Prostacyclin Market Report 2016

1 Prostacyclin Overview

1.1 Product Overview and Scope of Prostacyclin

1.2 Classification of Prostacyclin

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Prostacyclin

1.3.1 Health care

1.3.2 Clinic

1.3.3 Hospital

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Prostacyclin (2011-2021)

1.4.1 USA Prostacyclin Sales and Growth Rate (2011-2021)

1.4.2 USA Prostacyclin Revenue and Growth Rate (2011-2021)

2 USA Prostacyclin Competition by Manufacturers

2.1 USA Prostacyclin Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Prostacyclin Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Prostacyclin Average Price by Manufactures (2015 and 2016)

2.4 Prostacyclin Market Competitive Situation and Trends

2.4.1 Prostacyclin Market Concentration Rate

2.4.2 Prostacyclin Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Prostacyclin Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Prostacyclin Sales and Market Share by Type (2011-2016)

3.2 USA Prostacyclin Revenue and Market Share by Type (2011-2016)

3.3 USA Prostacyclin Price by Type (2011-2016)

3.4 USA Prostacyclin Sales Growth Rate by Type (2011-2016)

4 USA Prostacyclin Sales (Volume) by Application (2011-2016)

4.1 USA Prostacyclin Sales and Market Share by Application (2011-2016)

4.2 USA Prostacyclin Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Prostacyclin Manufacturers Profiles/Analysis

5.1 Actelion Pharmaceuticals Ltd.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Prostacyclin Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Actelion Pharmaceuticals Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 United Therapeutics Corporation

5.2.2 Prostacyclin Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Gilead sciences

5.3.2 Prostacyclin Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Gilead sciences Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Bayer AG

5.4.2 Prostacyclin Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 SteadyMed Ltd.

5.5.2 Prostacyclin Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 SteadyMed Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline plc

5.6.2 Prostacyclin Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline plc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Pfizer Inc.

5.7.2 Prostacyclin Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Pfizer Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Reata Pharmaceuticals Inc.

5.8.2 Prostacyclin Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Reata Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Arena Pharmaceuticals Inc.

5.9.2 Prostacyclin Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Arena Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co. Inc

5.10.2 Prostacyclin Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co. Inc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Prostacyclin Manufacturing Cost Analysis

6.1 Prostacyclin Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Prostacyclin

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Prostacyclin Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Prostacyclin Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Prostacyclin Market Forecast (2016-2021)

10.1 USA Prostacyclin Sales, Revenue Forecast (2016-2021)

10.2 USA Prostacyclin Sales Forecast by Type (2016-2021)

10.3 USA Prostacyclin Sales Forecast by Application (2016-2021)

10.4 Prostacyclin Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Prostacyclin

Table Classification of Prostacyclin

Figure USA Sales Market Share of Prostacyclin by Type in 2015

Table Application of Prostacyclin

Figure USA Sales Market Share of Prostacyclin by Application in 2015

Figure Health care Examples

Figure Clinic Examples

Figure Hospital Examples

Figure USA Prostacyclin Sales and Growth Rate (2011-2021)

Figure USA Prostacyclin Revenue and Growth Rate (2011-2021)

Table USA Prostacyclin Sales of Key Manufacturers (2015 and 2016)

Table USA Prostacyclin Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Prostacyclin Sales Share by Manufacturers

Figure 2016 Prostacyclin Sales Share by Manufacturers

Table USA Prostacyclin Revenue by Manufacturers (2015 and 2016)

Table USA Prostacyclin Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Prostacyclin Revenue Share by Manufacturers

Table 2016 USA Prostacyclin Revenue Share by Manufacturers

Table USA Market Prostacyclin Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Prostacyclin Average Price of Key Manufacturers in 2015

Figure Prostacyclin Market Share of Top 3 Manufacturers

Figure Prostacyclin Market Share of Top 5 Manufacturers

Table USA Prostacyclin Sales by Type (2011-2016)

Table USA Prostacyclin Sales Share by Type (2011-2016)

Figure USA Prostacyclin Sales Market Share by Type in 2015

Table USA Prostacyclin Revenue and Market Share by Type (2011-2016)

Table USA Prostacyclin Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Prostacyclin by Type (2011-2016)

Table USA Prostacyclin Price by Type (2011-2016)

Figure USA Prostacyclin Sales Growth Rate by Type (2011-2016)

Table USA Prostacyclin Sales by Application (2011-2016)

Table USA Prostacyclin Sales Market Share by Application (2011-2016)

Figure USA Prostacyclin Sales Market Share by Application in 2015

Table USA Prostacyclin Sales Growth Rate by Application (2011-2016)

Figure USA Prostacyclin Sales Growth Rate by Application (2011-2016)

Table Actelion Pharmaceuticals Ltd. Basic Information List

Table Actelion Pharmaceuticals Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Actelion Pharmaceuticals Ltd. Prostacyclin Sales Market Share (2011-2016)

Table United Therapeutics Corporation Basic Information List

Table United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table United Therapeutics Corporation Prostacyclin Sales Market Share (2011-2016)

Table Gilead sciences Basic Information List

Table Gilead sciences Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gilead sciences Prostacyclin Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Prostacyclin Sales Market Share (2011-2016)

Table SteadyMed Ltd. Basic Information List

Table SteadyMed Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table SteadyMed Ltd. Prostacyclin Sales Market Share (2011-2016)

Table GlaxoSmithKline plc Basic Information List

Table GlaxoSmithKline plc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline plc Prostacyclin Sales Market Share (2011-2016)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. Prostacyclin Sales Market Share (2011-2016)

Table Reata Pharmaceuticals Inc. Basic Information List

Table Reata Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Reata Pharmaceuticals Inc. Prostacyclin Sales Market Share (2011-2016)

Table Arena Pharmaceuticals Inc. Basic Information List

Table Arena Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals Inc. Prostacyclin Sales Market Share (2011-2016)

Table Merck & Co. Inc Basic Information List

Table Merck & Co. Inc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Inc Prostacyclin Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostacyclin

Figure Manufacturing Process Analysis of Prostacyclin

Figure Prostacyclin Industrial Chain Analysis

Table Raw Materials Sources of Prostacyclin Major Manufacturers in 2015

Table Major Buyers of Prostacyclin

Table Distributors/Traders List

Figure USA Prostacyclin Production and Growth Rate Forecast (2016-2021)

Figure USA Prostacyclin Revenue and Growth Rate Forecast (2016-2021)

Table USA Prostacyclin Production Forecast by Type (2016-2021)

Table USA Prostacyclin Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370